June 2026 brought the first working bridge between Cardano and Injective. ADA and INJ can now move between the two chains on testnet for the first time, with both teams eyeing a mainnet launch down the line.
The connection runs through IBC, the Inter-Blockchain Communication protocol that powers Cosmos. Instead of relying on wrapped tokens or third-party intermediaries, IBC lets chains talk directly at the protocol level.
Getting there took serious engineering. Cardano wasn't built for IBC compatibility. The chain runs on an extended UTXO model, while Injective uses an account-based architecture like most blockchains. The two teams had to develop custom modules to translate between these fundamentally different designs.
Injective, a Layer 1 built for trading and derivatives, already had IBC baked in since it's built on Cosmos SDK. The heavy lifting fell on Cardano's side. Development happened through the cardano-ibc-incubator GitHub repository, with the groundwork starting back in June 2024.
The bridge does more than shuffle tokens. Decentralized applications on both chains can now swap, exchange messages, and coordinate more complex interactions. Before the testnet activation, Injective ran an internal audit to squash technical issues and improve stability in the cross-platform tools.
Cardano's broader interchain ambitions are bigger. The network has been working to connect with over 115 blockchains in the wider interchain ecosystem. Injective is the first major testnet milestone, but both teams are already talking about expanding further into Cosmos and pushing the integration to mainnet.
This article is informational only and does not constitute financial advice. Testnet deployments carry experimental risks.